Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,578 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06953622Recruiting
Migraine and PFO: A Follow-up Study
This study is for people who have migraines and a small hole in their heart called a patent foramen ovale (PFO). It will track your health over time to learn more about how these conditions are related.
BeijingAges Any age - NCT06953687Recruiting
Shared decision making for PTSD treatment in active duty military
This trial tests a shared decision-making approach to help active duty military members with PTSD choose the best treatment for them. You and your doctor will work together to decide on a plan that fits your needs and values.
Fort Cavazos, TexasAges 18 years+ - NCT06954129RecruitingPhase 4
Comparing two antibiotic combos for infection and kidney safety
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06954155RecruitingPhase 3
Tenecteplase for stroke treatment 24-72 hours after symptoms start
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
BeijingAges 18 years+ - NCT06954246RecruitingPhase 3
New drug vs. doctor’s choice for relapsed small cell lung cancer
This trial tests a new drug called MHB088C for people with small cell lung cancer that has come back or gotten worse after standard treatments. It compares this drug to other options your doctor might choose. The goal is to see if MHB088C works better.
ShanghaiAges 18 years+ - NCT06954467RecruitingPhase 2
Two immunotherapy drugs for advanced liver cancer
This study tests two new immunotherapy drugs (JS207 and JS007) as a first treatment for advanced liver cancer. It might be an option if you have not had any prior cancer medicine and your liver tumor is not blocking the main portal vein.
Hefei, AnhuiAges 18 years+ - NCT06954831RecruitingPhase 2
Short-course radiation for early-stage breast cancer
This trial tests a shorter, more intense radiation schedule for people with stage I-III breast cancer after lumpectomy. It aims to find if giving a higher daily dose over fewer sessions is safe and effective.
Arcadia, CaliforniaAges 40 years+ - NCT06955052Recruiting
Maze activity for balance and walking in Down syndrome
This study tests a fun activity program called 'Minds In Motion The Maze' to see if it helps improve balance and walking in children with Down syndrome.
Lahore, Punjab ProvinceAges 8–12 - NCT06955156RecruitingPhase 2
Trilaciclib with immunotherapy and chemo for early TNBC
This trial tests a new drug combination for people with locally advanced triple-negative breast cancer who haven't had treatment yet. The goal is to see if adding trilaciclib to standard chemo and immunotherapy works better before surgery.
BeijingAges 18–75 - NCT06956001RecruitingPhase 3
Testing firmanertinib vs chemo for first-line lung cancer with specific EGFR mutations
This trial compares a new targeted therapy pill (firmanertinib) to standard chemotherapy in people with advanced non-small cell lung cancer whose tumors have a specific EGFR mutation (PACC or L861Q). If you haven't had treatment for advanced disease and your cancer matches these mutations, this study may offer a more convenient oral option.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06956118Recruiting
Improving sleep with nerve stimulation for visually impaired people
This trial tests a device that stimulates a nerve behind the ear to see if it helps improve sleep in people who are severely sight impaired or blind. You would need to visit the clinic for 30-minute sessions, 5 days a week, for 4 weeks.
BengaluruAges 18–80 - NCT06956183Recruiting
Balance exercises for stroke-related tiredness
This study tests if specific balance exercises can help reduce tiredness after a stroke. If you had a stroke at least 6 months ago and can walk a little, you may be able to join.
AnkaraAges 18–65 - NCT06956326RecruitingPhase 2
Early rehab for multiple sclerosis relapse recovery
This trial tests whether early and specialized rehabilitation can help people with multiple sclerosis recover better after a motor relapse. It is for people who are already staying at a Danish MS Hospital for rehab.
HaslevAges 18 years+ - NCT06956729Recruiting
Guided hip growth for children with cerebral palsy
This trial tests a surgery to help guide the growth of the hip bone in children with cerebral palsy whose hips are at risk of slipping out of place. The goal is to prevent hip dislocation and avoid more complex surgery later.
A Coruña, A CoruñaAges 3–8 - NCT06957093Recruiting
AI‐assisted diabetes care vs standard management
This study tests whether an AI‐powered digital health platform can help people with type 2 diabetes better manage their blood sugar. If you use a smartphone and have had diabetes for at least a year, this may be a convenient way to receive extra support.
Changchun, JilinAges 18–75 - NCT06957652Recruiting
Surgery for advanced gum disease around dental implants
This study tests a surgical technique to repair bone damage around dental implants caused by severe gum disease (peri-implantitis). It is designed for people with specific types of bone defects and healthy gums elsewhere in the mouth.
Ankara, TurkeyAges 18–75 - NCT06957964Recruiting
Does a special wound dressing help prevent infection after belly surgery?
This trial tests a special wound dressing (negative pressure therapy) used right after belly surgery to see if it helps prevent wound problems. It may be an option for people who are having a first-time laparotomy and are in good general health.
Lahore, Punjab ProvinceAges 20–70 - NCT06958419RecruitingPhase 2/Phase 3
Short radiation plus targeted drugs for advanced colon cancer
This trial tests a combination of short-course radiation, chemotherapy, targeted therapy (bevacizumab), and an immunotherapy drug (PD-1 inhibitor) for people with advanced colorectal cancer that has spread and is not curable with surgery. It aims to see if this approach can help shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06959095RecruitingPhase 3
Depemokimab for COPD with type 2 inflammation
This trial tests a new medicine, depemokimab, given as an injection to help reduce flare-ups (exacerbations) in adults with moderate to severe COPD who have a certain type of inflammation. The goal is to see if it can keep you healthier for longer with fewer serious breathing attacks.
Loxahatchee Groves, FloridaAges 40–80 - NCT06959173Recruiting
Personalized treatment for fluid around the lungs
This study uses lab-grown miniature versions of your cancer cells (organoids) to find which treatment might work best for you. It's for people with fluid around the lungs caused by cancer (malignant pleural effusion).
Zhengzhou, HenanAges 18 years+ - NCT06959251Recruiting
Glycine and magnesium with thiamine for primary ciliary dyskinesia
This trial tests whether a combination of glycine, magnesium, and thiamine can help people with primary ciliary dyskinesia (a condition that affects the tiny hairs in your lungs). It aims to see if these supplements improve breathing and reduce lung problems.
Mexico CityAges 5 years+ - NCT06959342Recruiting
Brain stimulation to reduce cravings in alcohol use disorder
This trial tests if a gentle brain stimulation technique (tDCS) can help people with alcohol use disorder control their cravings and drinking habits. It is an add-on to your regular treatment.
MannheimAges 18–65 - NCT06959641RecruitingPhase 2
XL092 for advanced thyroid cancer that no longer responds to radioactive iodine
This trial is testing a new oral medication, XL092, for people with advanced thyroid cancer that has stopped responding to radioactive iodine therapy. The goal is to see if XL092 can slow or stop the cancer from growing.
Torrance, CaliforniaAges 18 years+ - NCT06959719Recruiting
Air entrainment vs standard drainage for non-expandable lung
This trial tests whether a new method called 'air entrainment' (adding air during drainage) works better than standard drainage for people with a lung that doesn't fully expand. If you have persistent fluid buildup around the lung and are scheduled for drainage, you may be able to join.
Cambridge, CambridgeshireAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,578 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.